GLP1R and inflammatory bowel disease: Meta-analysis showed no effect of GLP1-RA on corticosteroid initiation in patients with IBD (logHR 1.02, 95% CI: 0.86-1.22, I2 = 46%, P = 0.79) (Figure 3).